简介:The use of monoclonal antibodies (mAb) has been accepted as an effective cure for the treatment of cancer and autoimmune diseases. Rising time and cost pressures in combination with the demand for higher throughput make 简介:The use of monoclonal antibodies (mAb) has been accepted as an effective cure for the treatment of cancer and autoimmune diseases. Rising time and cost pressures in combination with the demand for higher throughput make the development of therapeutic antibodies challenging.详细>